Results     20-May-25
Announcements
Zydus Lifesciences consolidated net profit declines 0.96% in the March 2025 quarter
Sales rise 17.21% to Rs 6290.20 crore
Net profit of Zydus Lifesciences declined 0.96% to Rs 1170.90 crore in the quarter ended March 2025 as against Rs 1182.30 crore during the previous quarter ended March 2024. Sales rose 17.21% to Rs 6290.20 crore in the quarter ended March 2025 as against Rs 5366.40 crore during the previous quarter ended March 2024.

For the full year,net profit rose 17.26% to Rs 4525.50 crore in the year ended March 2025 as against Rs 3859.50 crore during the previous year ended March 2024. Sales rose 18.68% to Rs 22573.80 crore in the year ended March 2025 as against Rs 19021.50 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear Ended
Mar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.
Sales6290.205366.40 17 22573.8019021.50 19
OPM %33.7930.38 -31.2728.31 -
PBDT2129.501752.30 22 7162.105587.20 28
PBT1891.601547.00 22 6246.304823.10 30
NP1170.901182.30 -1 4525.503859.50 17

Previous News
  Nifty slips below 25,850 mark; realty shares witness profit booking
 ( Market Commentary - Mid-Session 12-Feb-26   11:33 )
  Zydus Lifesciences gains on settlement with Astellas over Myrbetriq
 ( Hot Pursuit - 12-Feb-26   10:49 )
  Zydus update on settlement agreement with Astellas
 ( Corporate News - 12-Feb-26   09:13 )
  Zydus Lifesciences
 ( Analyst Meet / AGM - Conference Call 10-Feb-26   11:38 )
  Zydus Lifesciences
 ( Results - Analysis 09-Feb-26   15:39 )
  Zydus Lifesciences consolidated net profit rises 1.82% in the December 2025 quarter
 ( Results - Announcements 09-Feb-26   16:59 )
  Zydus receives USFDA Orphan drug designation for Desidustat
 ( Corporate News - 06-Feb-26   12:45 )
  Zydus receives USFDA tentative approval for Dapagliflozin Tablets
 ( Corporate News - 04-Feb-26   16:07 )
  Zydus Lifesciences to discuss results
 ( Corporate News - 28-Jan-26   10:46 )
  Zydus Lifesciences' Ankleshwar unit completes USFDA inspection
 ( Corporate News - 24-Jan-26   10:51 )
  Zydus Lifesciences launches world's first biosimilar of Nivolumab in India
 ( Corporate News - 22-Jan-26   12:54 )
Other Stories
  Aban Offshore reports consolidated net profit of Rs 29.56 crore in the December 2025 quarter
  13-Feb-26   17:35
  Ironwood Education reports consolidated net profit of Rs 5.24 crore in the December 2025 quarter
  13-Feb-26   17:35
  Yuken India reports consolidated net loss of Rs 0.51 crore in the December 2025 quarter
  13-Feb-26   17:35
  Prag Bosimi Synthetics reports consolidated net loss of Rs 1.68 crore in the December 2025 quarter
  13-Feb-26   17:35
  VLS Finance reports consolidated net profit of Rs 18.05 crore in the December 2025 quarter
  13-Feb-26   17:35
  Tilaknagar Industries reports consolidated net loss of Rs 105.41 crore in the December 2025 quarter
  13-Feb-26   17:35
  Capital India Finance reports consolidated net loss of Rs 2.92 crore in the December 2025 quarter
  13-Feb-26   17:35
  Jindal Worldwide consolidated net profit declines 22.33% in the December 2025 quarter
  13-Feb-26   17:35
  Empower India consolidated net profit rises 1.90% in the December 2025 quarter
  13-Feb-26   17:35
  BGR Energy Systems reports consolidated net loss of Rs 192.81 crore in the December 2025 quarter
  13-Feb-26   17:35
Back Top